A phase II study of MEK162 (binimetinib [BINI]) in combination with imatinib in patients with untreated advanced gastrointestinal stromal tumor (GIST).Ping Chi, William D. Tap, Li‐Xuan Qin et al.|Journal of Clinical Oncology|2020Cited by 21
Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, William D. Tap, Niedzica Camacho et al.|Clinical Cancer Research|2022Cited by 16
A phase 1b study of avelumab plus DCC-3014, a potent and selective inhibitor of colony stimulating factor 1 receptor (CSF1R), in patients with advanced high-grade sarcoma.Evan Rosenbaum, Sandra P. D’Angelo, Sujana Movva et al.|Journal of Clinical Oncology|2021Cited by 12
A phase I study of the CSF1R inhibitor vimseltinib in combination with the PD-L1 inhibitor avelumab in patients with advanced sarcomaEvan Rosenbaum, Sandra P. D’Angelo, Kenneth Seier et al.|ESMO Open|2025Cited by 6
Supplementary Data from Phase Ib Trial of the Combination of Imatinib and Binimetinib in Patients with Advanced Gastrointestinal Stromal TumorsPing Chi, William D. Tap, Li‐Xuan Qin et al.|Unknown|2023Cited by 0